Hallucinations

Download PDF

Recent Publications on Hallucinations:
How Frequent is Chronic Multiyear Delusional Activity and Recovery in Schizophrenia: A 20-Year Multi-follow-up. To determine how frequent chronic multiyear delusional activity is in...	12th July, 2008	2Department of Psychiatry, University of Illinois College of Medicine,	Schizophr Bull. 2008 Jul 9;. DOI Direct Link
Psychosocial and intellectual functioning in childhood narcolepsy. Purpose: This study reports the psychological assessment of 12 children...	9th July, 2008	Fraser of Allander Neurosciences Unit, Glasgow, UK.	Dev Neurorehabil. 2008 Apr 1;:1-8. DOI Direct Link
Ingestions of benzydamine-containing vaginal preparations. Objective. Benzydamine is a non-steroidal antiinflammatory drug used as...	9th July, 2008	Servicio de Informacion Toxicologica, Spanish Poison Control Centre,	Clin Toxicol (Phila). 2008 Mar 25;:1-5. DOI Direct Link
Hallucinations in adolescent inpatients with post-traumatic stress disorder and schizophrenia: similarities and differences. Objective: This study compares the phenomenology of hallucinations in a...	9th July, 2008	Child and Youth Mental Health Service, Royal Children's Hospital and	Australas Psychiatry. 2008 Jun 12;:1-5. DOI Direct Link
Abnormal sleep and sleepiness in Parkinson's disease. PURPOSE OF REVIEW: Sleep problems are frequent and disabling in patients...	9th July, 2008	Sleep Disorders Unit, Pitie-Salpetriere Hospital, Assistance	Curr Opin Neurol. 2008 Aug;24(4):472-7. DOI Direct Link
→View more research publications.

BioNews Results for Hallucinations:
FDA Approves Requip® XL™, The First And Only Oral Once-Daily Non-Ergot Dopamine Agonist For Parkinso	Pharmaceutical Online:  Jun 18 2008 1:15PM Matching: hallucinations
U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinso	PR Newswire via Yahoo!:  Jun 16 2008 1:21AM Matching: hallucinations
U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinso	SmartBrief:  Jun 14 2008 4:04PM Matching: hallucinations
U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinso	TickerTech.com:  Jun 13 2008 10:34PM Matching: hallucinations
U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily	FinanzNachrichten.de:  Jun 13 2008 9:37PM Matching: hallucinations
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Hallucinations Clinical Trials:
Survey on Parkinson's Disease (PD) Patients With Depressive Symptoms	Parkinson Disease
An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression	Major Depressive Disorder;   Psychotic Disorders
A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression	Major Depressive Disorder;   Psychotic Disorders
A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression	Major Depressive Disorder;   Psychotic Disorders
An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression	Major Depressive Disorder
→View more trials.

Hallucinations Patents:
US Patent No.	Title
7320979	N-[(piperazinyl)hetaryl]arylsulfonamide compounds
7351707	Spiroazacyclic compounds as monoamine receptor modulators
7353064	Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of movement disorders and/or other neurologic dysfunction
7353065	Responsive therapy for psychiatric disorders
7354918	Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol and applications thereof
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hallucinations scientists - we have details of around 985 individuals working on Hallucinations .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.